Galanin is a neuropeptide with a wide variety of biological functions. Few nonpeptide ligands, capable of activating galanin receptors, are available today. Based on known pharmacophores of galanin and the tripeptidomimetic galnon, a combinatorial library was formulated, synthesized, and screened against the galanin receptor. An active compound, galmic, was identified and tested in vitro and in vivo for its affinity and efficacy at galanin receptors. The present work describes the total synthesis of galmic, the synthesis of its oxazole precursors, the coupling of the building blocks into a linear trimer, and the macrolactamization reaction.
Galanin is a neuropeptide with a wide variety of biological functions. Few nonpeptide ligands, capable of activating galanin receptors, are available today. Based on known pharmacophores of galanin and the tripeptidomimetic galnon, a combinatorial library was formulated, synthesized, and screened against the galanin receptor. An active compound, galmic, was identified and tested in vitro and in vivo for its affinity and efficacy at galanin receptors. The present work describes the total synthesis of galmic, the synthesis of its oxazole precursors, the coupling of the building blocks into a linear trimer, and the macrolactamization reaction.
galnon ͉ mimetic G alanin is a 29-aa-long (30 aa in humans) neuroendocrine peptide, whose physiological functions are regulated by G protein-coupled receptors. Galanin is found throughout the central and peripheral nervous systems and the gastrointestinal tract (1) (2) (3) (4) . The effects of this peptide include inhibition of insulin release (5-7), inhibition of neurotransmiters involved in regulation and memory acquisition (8) , modulation of food intake (9, 10) and sexual behavior (11) , as well as effects on controlling pain threshold (12, 13) and in the pathogenesis of Alzheimer's disease (14) .
Studies involving L-Ala-substituted analogues of galanin have identified Trp-2, Asn-5, and Tyr-9 as well as the N-terminal amino group as being critical determinants for receptor binding. These amino acids are located in the N-terminal helical part of galanin that it is made up of the same 15 aa in all species from which it was isolated (15, 16) . Fragments of galanin have shown low binding affinity but these peptides are vulnerable to the action of the peptidases and unable to cross the blood-brain barrier (17, 18) . Two nonpeptide antagonists of the galanin receptor have been reported, spirocoumaranon (Sch202596) (19) and 2,3-dihydro-2-(4-methylphenyl)-1,4-dithiepin-1,1,4,4-tetroxide (20) (see Fig. 1 ), but there is only one nonpeptide galanin receptor ligand, galnon, that shows agonist activity (21) .
In this study, we report an example of a nonpeptide subtype selective agonist for the galanin receptor, galmic, discovered by application of a combinatorial library approach (22) .
Methods
Experimental. Reactions were performed under an argon atmosphere, NMR spectra were recorded on a Bruker DRX 600 spectrometer (unless otherwise mentioned), and the chemical shifts are given in ppm relative to tetramethylsilane. The spectra were referenced to deuterated solvents indicated in brackets in the analytical data. High-resolution MALDI-Fourier transform MS (FTMS) measurements were performed on an IonSPec (Lake Forest, CA) FTMS mass spectrometer by using 2,5-dihydroxybenzoic acid as the matrix. For TLC, silica plates IB2-F (J. T. Baker) were used. For column chromatography, silica gel 60, 230-400 mesh (Merck) was used. Preparative chromatographic plates and silica gel 60 F 254 (20 ϫ 20 cm, 0.5 mm) were used. Anhydrous solvents and chemicals were used as purchased from commercial suppliers.
General Procedures. (i) Peptide coupling conditions. To a stirred solution of acid compound (1 eq) and the trifluoroacetic acid (TFA) salt of the amino compound (1 eq) in N,N-dimethylformamide (DMF) (0.2 M) were added diphenylphosphine azide (1.2 eq) or 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDCI) (1.2 eq), and Nhydroxybenzotriazole (HOBt) (1.2 eq) at Ϫ20°C followed by the slow addition of N,N-diisopropylethylamine (DIEA) (3.6 eq). Stirring was continued for 20 h while the mixture was warmed up to room temperature (RT). Solvent was evaporated, and the residue was dissolved in EtOAc and extracted with 5% aqueous HCl, saturated NaHCO 3 solutions, and brine. The organic layer was dried over MgSO 4 and concentrated in vacuo. Purification was accomplished by chromatography on silica gel by using EtOAc͞ hexanes as eluent.
(ii) Hydrolysis of the methyl esters. Method a. The methyl ester was dissolved in a NaOH 5% solution in ethanol while cooling at 0°C. After 10 min, the reaction was completed and the solution was acidified with 5% HCl solution until pH ϭ 1. Then EtOAc was added and the two phases separated; the organic layer was dried over MgSO 4 and evaporated in vacuo to yield the corresponding acid.
Method b. The methyl ester was dissolved in acetone (0.1 M) and a solution of LiOH (1 eq) in H 2 O was added while cooling at 0°C. After 10 min, the reaction was completed and the solution was acidified with 5% HCl solution until pH ϭ 1. Then EtOAc was added, and the organic layer was separated, dried over MgSO 4 , and evaporated in vacuo to yield the corresponding acid.
(iii) Synthesis of oxazole building blocks. To a stirred solution of dipeptide (1 eq) in dichloromethane (DCM) (0.1 M) was added Dess-Martin periodinane (1.5 eq) at 0°C. The ice bath was removed after 30 min and the mixture was stirred for 4 h longer at RT. To this mixture saturated Na 2 S 2 O 3 and NaHCO 3 solutions were added and stirring was continued for 45 min. Then the phases were separated and the organic layer was washed with brine, dried over MgSO 4 , and concentrated in vacuo. The amidoketone was purified by flash chromatography using a mixture of EtOAc͞hexanes (1:2) as eluent. To a stirred solution of the ketone in DCM (0.01 M), triethylamine (4 eq) and 4-dimethylaminopyridine (DMAP) (0.1 eq) were added. The mixture was stirred for 1 h and then triphenylphosphine (1 eq) and iodine (1 eq) were added at 0°C. The cooling bath was removed after 20 min, and stirring was continued at RT for 2 h. The solvent was removed in vacuo, the residue was dried overnight and diluted with diethylether, and the triphenylphosphine oxide was filtrated. Pure oxazole was obtained after chromatography on silica gel by using EtOAc͞hexanes (1:4) as eluent.
(iv) Deprotection of t-butyloxycarbonyl (Boc). Protected compound was dissolved in anhydrous DCM (0.1 M) and TFA (50-100 eq) was added slowly at RT. Stirring was continued until TLC showed the consumption of all starting material (usually 0.5-3 h) then the mixture was concentrated in vacuo (EtOAc or MeOH was coevaporated several times to remove traces of TFA) to yield the TFA salt of the pure deprotected amino compound. 1 eq) and N,N-dicyclohexylcarbodiimide (1.1 eq) were added while cooling at Ϫ20°C. The reaction mixture was allowed to warm to RT overnight, filtered from urea, and evaporated. (vii) Macrolactamization reaction. The linear trimer (1 eq) was injected dropwise into a solution of DMAP (3 eq) in toluene at 95°C. After the addition, the macrocycle was the only product detected by TLC. Solvent was evaporated and residue was purified by chromatography on silica gel by using EtOAc͞hexanes as eluent.
Synthesis of the Library Mixtures.
To a solution of the triacid platform 1 (1 eq) and the amines cyclohexylmethylamine 2 (1 eq), 9-fluorenylmethylamine 3 (1 eq) and -t-Boc-l-lysine 4 (1 eq) or the amino acids Trp (1 eq), Asn (1 eq), and Tyr (1 eq) in DMF (0.2M) were added to EDCI (1.2 eq), and HOBt (1.2 eq) at Ϫ20°C followed by the slow addition of DIEA (3.6 eq). Stirring was continued for 20 h while allowing the mixture to warm up to RT. Solvent was removed in vacuo, and the obtained residue was washed with 10% HCl and saturated NaHCO 3 solutions to remove any unreacted starting material. The mixtures were treated with 50% TFA in DCM and stirred for 1 h to deprotect the Boc side chains. After this time reaction mixtures were dried by evaporation and filtrated upon precipitation with diethyl ether.
The libraries were analyzed by HPLC-MS for characterization. Experiments were performed on an IonSPec FTMS mass spectrometer operated in the electrospray ionization mode. The column used was a Biobasic C4 with a flow rate of 1.5 ml͞min. The gradient was of 20% acetonitrile (MeCN) (0.05% TFA) in H 2 0 (0.05% TFA) for 2 min followed by a gradient of 50% MeCN (0.05% TFA) in H 2 0 (0.05% TFA) for 18 min and then holding for another 20 min. The wavelength used for the detection was 213 nm. The mass range was m͞z from 500 to 1,300.
The peaks corresponding to the expected products were detected and mixture was screened for 125 I-galanin displacement activity in equilibrium binding assay. The mixture was then deconvoluted by HPLC under the same conditions described above. Fractions were collected every 2 min. In total, 20 fractions were further purified. Fractions were collected, analyzed by HPLC-MS, freeze-dried, and screened for 125 I-galanin displacement activity.
Synthesis of Diester 13. To a solution of 60 g (0.24 mol) of carboxylic acid 12 in 1 liter of DCM at RT, 55.5 g (1.1 eq) of N,Ndicyclohexylcarbodiimide, 30 ml of isopropanol (1.5 eq), and 3 g (0.1 eq) of DMAP were added. The reaction mixture was stirred for 20 h at RT. The solution was filtered and concentrated. The residue was purified by flash chromatography on silica gel (AcOEt͞ hexanes, 1:3) to give 59 g (84%) of a white solid. 1 To a solution of 59 g (0.2 mol) of diester 13 in 560 ml of tetrahydrofuran (THF), 11 g (1.3 eq) of lithium hydroxide in 280 ml of water was added at 0°C. The reaction mixture was allowed to warm up to RT for 30 min. THF was evaporated under reduced pressure (T Ͻ 35°C), and the residue was acidified with 400 ml of 5% HCl. The carboxylic acid was extracted with 3 ϫ 400 ml of Et 2 O, and the organic phase was separated, washed with 200 ml of brine, dried over MgSO 4 , and concentrated to give 56 g (98%) of carboxylic acid 14 as an viscous oil. 1 Synthesis of Peptide 15b. To a solution of 17 g (61.75 mmol) of carboxylic acid 5 in 340 ml of tetrahydrofuran at Ϫ20°C was added 6.8 ml (1 eq) of N-methylmorpholine and 8 ml (1 eq) of isobutylchloroformate. The reaction mixture was allowed to warm up to 0°C in 30 min. A suspension of 13.6 g of 9-f luorenylamine hydrochloride (1 eq) in 70 ml DMF was added followed by 6.8 ml (1 eq) of N-methylmorpholine. The reaction mixture was stirred at RT for 5 h. The solvent was evaporated, and 850 ml of EtOAc was added. The organic phase was washed with 2 ϫ 170 ml of water, 170 ml of HCl 5%, and 170 ml of saturated solution of NaCl, dried over MgSO 4 , evaporated, and purified by f lash chromatography on silica gel (EtOAc͞hexanes, 1:4; Rf ϭ 0.24) to give 18 g (65%) of a white solid. 1 
Synthesis of the Pentafluorophenyl Ester 21.
The benzyl ester of the trimer 20 (1.50 g) was deprotected following general procedure v to give the corresponding acid that was coupled with pentafluorophenol following general procedure vi. Deprotection of the Boc group following general procedure iv afforded the trimer 21 in a 82% overall yield (1.20 g). 1 
Results and Discussion
Synthesis of the Combinatorial Library. A solution phase-activated core approach was used for the synthesis of the combinatorial library. This approach can be divided into three components: the core, linker, and building blocks. As core molecule we used the triacid platform 1 developed in this research group (23) (24) (25) , this triacid was inspired by a number of biologically active and peptidederived marine natural products such as dendroamide C (26) (27) (28) (29) (30) . These macrocycles feature oxazole rings linked by trans amide bonds. The most favored conformation features all lone pairs of oxazole nitrogens and the hydrogens of secondary amides directed to the center of the macrocycle, so the molecule is expected to be rigid and planar. The advantage of these molecules is that they can present structural diversity on a well defined rigid platform; the three side chains can act at the same time on the surface of the target. Fig. 2 presents the synthesis of the libraries. The first step was the coupling of the triacid core molecule 1 with two sets of amines as building blocks: cyclohexylmethylamine 2, 9-fluorenylamine 3, and -t-Boc-L-lysine methyl ester 4 (based on the structure of the galnon) or the amino acids Trp, Asn, and Tyr (based on the pharmacophore groups of the galanin). We used EDCI in DMF as coupling reagent. After removing the solvent in vacuo, libraries were purified by washing the obtained residue with 10% HCl and saturated NaHCO 3 solutions to remove any unreacted starting material. The mixtures were treated with 50% TFA in DCM and stirred for 1 h to deprotect the Boc side chains. After this time reaction mixtures were dried by evaporation and filtered upon precipitation with diethyl ether. All of the libraries were analyzed by HPLC-MS for initial characterization and screened for 125 Igalanin displacement activity in equilibrium binding assay. The structure of the most active compound (structure 5, galmic or its cyclodiastereomer) was deduced reiteratively by deconvolution of the libraries. The different fractions were tested in the binding assay and the compounds present were identified by MS.
Synthesis of the Individual Compounds. The disconnection at the amide bonds of 5 leads to three oxazoles, each containing an amino and acid terminus and carrying the appropriate side chain. The exception is the amine 4 derivative that we decided to introduce as a protected lysine after the macrocyclization reaction, at the end of the synthesis (Fig. 3) . This coupling is approximately the same reaction as was encountered during the synthesis of the active mixture. We chose the oxazole 7 as its precursor (23) . The three different monomers 7, 8a and 8b, could be attached and successive steps of deprotection-coupling led to the cyclic product 6. Then the methyl ester could be hydrolyzed and coupled with -t-Boc-L-lysine 4 that, after Boc deprotection, afforded the enantiomerically pure galmic 5.
Following the procedure described (23), oxazole 9 was synthesized. The methyl ester of 9 was selectively hydrolyzed in the presence of the benzyl ester by using aqueous LiOH in acetone. Although acid 10 was detected, all our attempts to couple it with cyclohexylmethylamine 2 or 9-fluorenylamine 3 to give the corresponding oxazoles 8a and 8b were unsuccessful, and the decarboxylated product 11 was the only product isolated (Fig. 4) .
The oxazoles 8a and 8b can be traced back to a dipeptide, which consists of threonine coupled to an amino acid carrying the desired side chain. The synthesis of the oxazoles started with the transformation of optically active amino acid 12 (23) into the enantiopure amino acid 14, which was then coupled with the selected amines to give amides 15 a and b (Fig. 5) . In both cases, the isopropyl ester was hydrolyzed under basic conditions and the resulting acid 16 was coupled with L-threonine by using EDCI as dehydrating reagent. Then after the oxidation of the hydroxy group by using Dess-Martin periodinane, the synthesis of oxazoles 18 a and b was accomplished in good yield by treating the corresponding amidoketone with PPh 3 in the presence of I 2 and Et 3 N (31). Following the conditions reported in the literature, the desired product was obtained in low yield (30-40%). We observed the formation of side products probably because of the competition between the two amide groups present in the molecule. The yields were significantly improved by reversing the addition of the reagents. We first formed the enolate by treatment of the ketone with triethylamine and DMAP in DCM. The mixture was allowed to react for 1 h at RT and then cooled to 0°C, then PPh 3 was added followed by the slow addition of iodine. Monomers 8 a and b were obtained (after Boc deprotection with TFA) in excellent yield.
Once prepared, the three monomers were taken through the successive steps of deprotection and coupling of the amines to acids to give linear trimer 21 (Fig. 6 ). Oxazoles 7 and 8a were coupled to form the protected dimer 19 by using EDCI. The hydrogenation of the benzyl ester and coupling with 8b afforded the linear trimer 20. Although there are several methods available for peptide cyclizations, in many examples the ring closure via the pentafluorophenyl ester method shows exceptional results (32, 33) . Thus, benzyl ester 20 was transformed into a pentafluorophenyl ester, as depicted in Fig. 6 . The Boc group was deprotected with TFA, and without purification the resulting residue was injected dropwise into a solution of DMAP in toluene at 95°C. The cyclic product was the only product detected by TLC, no polymerization was observed, and 6 could be obtained in a 72% yield after purification.
As we previously described, the lysine side chain was introduced in the last steps of the synthesis. After the hydrolysis of methyl ester 6 under basic conditions, the -t-Boc-L-lysine was coupled by using EDCI in DMF. Boc cleavage afforded the enantiomerically pure galmic (5) in good yield (Fig. 7) .
Following a similar sequence, cyclodiastereomer 25 was obtained (see Supporting Text, which is published as supporting information on the PNAS web site, for more details).
In vitro assays showed that substituted macrocycle 5 (galmic) possessed a selective affinity for galanin receptor GalR1 at micromolar concentrations (K i ϭ 34.2 M). In addition, in vivo experiments in rats showed that galmic penetrates the blood-brain barrier quickly and exhibits agonist-like properties that mimic the galanin neuropeptide (22) . No such properties were found for cyclodiastereomer 25.
In summary, the synthesis of a small combinatorial library of molecules by using triacid platform 1 led to the discovery of galmic, a nonpeptide agonist of the galanin receptor GalR1. The total synthesis of galmic and its cyclodiastereomer allowed the definition of structure and provided sufficient material to study their biological properties in vivo. 
